CORC  > 武汉大学
Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
Yuan, Shen-Jun; Xu, Yong-Hong; Wang, Chao; An, Hui-Chao; Xu, Hua-Zhen; Li, Ke; Komatsu, Naoki; Zhao, Li; Chen, Xiao
刊名JOURNAL OF NANOBIOTECHNOLOGY
2019
卷号17期号:1
关键词Doxorubicin-polyglycerol-nanodiamond conjugate Triple-negative breast cancer Chemoresistance Immunosuppression Immunochemotherapy
DOI10.1186/s12951-019-0541-8
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4233785
专题武汉大学
推荐引用方式
GB/T 7714
Yuan, Shen-Jun,Xu, Yong-Hong,Wang, Chao,et al. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer[J]. JOURNAL OF NANOBIOTECHNOLOGY,2019,17(1).
APA Yuan, Shen-Jun.,Xu, Yong-Hong.,Wang, Chao.,An, Hui-Chao.,Xu, Hua-Zhen.,...&Chen, Xiao.(2019).Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.JOURNAL OF NANOBIOTECHNOLOGY,17(1).
MLA Yuan, Shen-Jun,et al."Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer".JOURNAL OF NANOBIOTECHNOLOGY 17.1(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace